WILLIAM DIEBOLD: Open Payments
NPI 1770573511 · JOHNSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 47 payments from 9 companies in 2025. Trend: 2023 $291 · 2024 $879 · 2025 $801
Food & beverage: $801
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $166 |
| Vanda Pharmaceuticals Inc. | 12 | $161 |
| Teva Pharmaceuticals USA, Inc. | 9 | $160 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $76 |
| Lundbeck LLC | 4 | $65 |
| Neurocrine BioSciences, Inc. | 3 | $61 |
| ABBVIE INC. | 3 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $29 |
Products named: AUSTEDO XR, REXULTI, HETLIOZ, CAPLYTA, INGREZZA, ABILIFY MAINTENA, VRAYLAR, COBENFY.
Industry payments across TN — which companies pay providers there.
